Sort   by:  
 Page size 
UnknownEfficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study.
Not available
S-EPMC3906835 | biostudies-literature
UnknownClinical efficacy, radiographic progression, and safety through 156 weeks of therapy with subcutaneous golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis despite prior methotrexate therapy: final results of the randomized GO-FORTH trial.
Not available
S-EPMC4924564 | biostudies-literature
UnknownGolimumab monotherapy in Japanese patients with active rheumatoid arthritis despite prior treatment with disease-modifying antirheumatic drugs: results of the phase 2/3, multicentre, randomised, double-blind, placebo-controlled GO-MONO study through 24 weeks.
Not available
S-EPMC3756456 | biostudies-literature
UnknownGolimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study.
Not available
S-EPMC3372319 | biostudies-literature
Sort   by:  
 Page size